Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Clin Immunol. 2013 Mar 6;147(2):105–119. doi: 10.1016/j.clim.2013.02.015

Figure 2. GA treatment reduces CD4/CD8 T cell ratio in the peripheral blood 12h post injection.

Figure 2

CD4+ (Panel A), CD8+ (Panel B) percentages and CD4/CD8 T cell ratio (Panel C) were determined in the peripheral blood of HD, untreated and GA-treated MS patients at indicated time points. Each point represents a single subject. Panels D and E show trends for CD8+ T cell percentages and CD4/ CD8 ratio, respectively, at 0 vs. 12h in the GA-treated group. Significant p values are indicated.